消化道狭窄的内镜治疗.ppt
- 文档编号:2105573
- 上传时间:2022-10-26
- 格式:PPT
- 页数:51
- 大小:7.28MB
消化道狭窄的内镜治疗.ppt
《消化道狭窄的内镜治疗.ppt》由会员分享,可在线阅读,更多相关《消化道狭窄的内镜治疗.ppt(51页珍藏版)》请在冰豆网上搜索。
消化道狭窄的内镜治疗病理类型病理类型qq我国我国我国我国鳞癌为主鳞癌为主鳞癌为主鳞癌为主97.6%97.6%上上上上1/31/3段段段段8.8%8.8%中中中中1/31/3段段段段65.9%65.9%下下下下1/31/3段段段段25.3%25.3%qq西方国家西方国家西方国家西方国家以下段食管为主、主要为腺癌(以下段食管为主、主要为腺癌(以下段食管为主、主要为腺癌(以下段食管为主、主要为腺癌(6060以上)以上)以上)以上)食管癌的治疗食管癌的治疗(强调早期发现、早期诊断、早期治疗)手术治疗手术治疗-姑息性手术姑息性手术-根治性手术根治性手术内镜下治疗内镜下治疗-食管扩张,食管支架取代传统的旁路手术食管扩张,食管支架取代传统的旁路手术-内镜下电灼切除、内镜下电灼切除、Nd:
YAG激光切除、激光切除、光动力疗法等光动力疗法等化疗:
化疗:
5-Fu和顺铂为主和顺铂为主放疗:
外放射为主放疗:
外放射为主以手术为主的综合治疗以手术为主的综合治疗手术适应证早期食管癌早期食管癌中期(中期()、中下段食管癌病变在)、中下段食管癌病变在5cm内,上段在内,上段在3cm内,全身情况好者内,全身情况好者中期(中期()、病变在)、病变在5cm以上,无明显远处转移,以上,无明显远处转移,全身条件允许,可采用术前放化疗与手术综合疗法全身条件允许,可采用术前放化疗与手术综合疗法放射治疗后复发,病变范围尚不大,无远处转移,放射治疗后复发,病变范围尚不大,无远处转移,全身情况良好者全身情况良好者手术禁忌证手术禁忌证食管癌病变广泛或累及邻近器官如气管、食管癌病变广泛或累及邻近器官如气管、肺、纵隔等者肺、纵隔等者已有锁骨上窝淋巴结等远处转移者已有锁骨上窝淋巴结等远处转移者有严重心、肺或肝功能不全者有严重心、肺或肝功能不全者严重恶病质者严重恶病质者Surgicalresectionistheonlycurativetreatmentoptionforinvasiveesophagealcancer.However,despitecarefulstagingandadvancesinadjuvanttherapyandsurgicaltechniques,5-yearsurvivalratesrarelyexceed40%.1,2Manypatientspresentwithlocoregionalrecurrenceanddistantmetastasiswithin2yearsaftercurativeesophagectomy.3Treatmentofpatientswithlocaldiseaserecurrenceaimsatrelievingdysphagia食管气管瘘金属支架置放术复查碘油造影未见造影剂瘘出。
EsophagealdiseasesandtypesofSEMSusedUUCUEGZWEsophagealcarcinomaCervical(n=14)77Thoracic(n=93)3147735G-Ejunction(n=79)442627Locallyrecurrentcarcinoma1236(n=48)Achalasia(n=8)44UU,UncoveredUltraflex(BostonScientific,Boston,Mass.);CU,coveredUltraflex(BostonScientific);E,Esophacoil(InstentInc.,EdenPrarie,Minn.);GZ,GianturcoZ-stent(CookInc.,Bloomington,Ind.);W,Wallstent(BostonScientific).Factorsthatmaypredisposetoesophagealstentmigration:
multivariateanalysisNMigration(%)pvalueGenderFemale588/13(61.5)0.0038StrictureTC802/13(15.4)0.954GEJ679/13(11.4)0.017EAC82/13(25)0.625PrevioustherapyS+B42/13(15.4)0.997R102/13(15.4)0.997Dilation10mm246/13(46.1)0.000StentGZ32/13(15.4)0.719E124.13(30.7)0.104UU874/13(30.7)0.169CU953/13(23.0)0.166TC,Esophagealthoraciccarcinoma;GEJ,carcinomaofthegastroesophagealjunction;EAC,esophagealachalasia;S+B,surgery&balloondilation;R,radiotherapy;GZ,GianturcoZ-stent;E,Esophacoil;UU,uncoveredUltraflex;CU,coveredUltraflex(GastrointestEndosc2001;53:
96-97.)EsophagealstentsformalignantstricturesclosetotheupperesophagealsphincterGastrointestEndosc2007;66:
1082-90EsophagealstentsforthepalliationofmalignantdysphagiaandfistularecurrenceafteresophagectomyLuminalpatency.Themediansurvivaltimeafterstentingforallpatientswithstenosiswas70days(range1dayto34months).Stentinsertionwastechnicallysuccessfulinallbut1patient(98%)(Fig.1).Mediandurationofprimarystentpatencywas56days(range1dayto33months)(Fig.2).Atotalof20episodesofstentdysfunctionoccurredin18(27%)of66patientsatamedianof38dayspost-SEMSinsertion(range2-406days).Stentdysfunctionwascausedbytissuein-orovergrowth(n8),stentmigration(n9),andfoodimpaction(n3).Tissuein-andovergrowthoccurredatamedianof119dayspost-SEMSinsertion(range33297days);5patientsweresuccessfullytreatedwithasecondSEMS.Six(24%)of25fullycoveredstentsversus3(7%)of41partiallycoveredSEMSmigrated(P.07)atamediantimeintervalof66daysafterSEMSinsertion(range12-406days).Ofthesepatients,6patientsrequiredasecondSEMS.Foodbolusimpactionoccurredin3(20%)patientsatamediantimeintervalof11daysafterSEMSinsertion;all3weresuccessfullyclearedendoscopically.InsertionofasecondSEMSwassuccessfulinallpatients(100%).Medianpatencyofthesestentswas59days(range5286days)Fistulasealing.Themediansurvivaltimeofpatientswithmalignantfistulacausedbytumorrecurrencewas73days(range10daysto91months).Thecoatedsegmentofthestenteffectivelysealedfistulaeinallbut1patient(93%).Thispatientwassuccessfullytreatedwithasecondstent.Stentdysfunctionoccurredin6(40%)of15patients.In5(33%)patients,additionalstentsweresuccessfullyinsertedtomanagestentmigration(n4)andpersistentleakageduringstenttreatment(n1).Two(22%)of9fullycoveredstentsversus2(33%)of6partiallycoveredSEMSsmigratedatamediantimeintervalof5monthspost-SEMSinsertion(range5daysto11months).Foodbolusimpactionoccurredin1patient17dayspost-SEMSinsertion,thispatientwasalsosuccessfullytreatedendoscopicallybystentclearance.OverallcomplicationsMildcomplicationsafterstentplacementoccurredin7(9%)patientsincludingretrosternalpainandsymptomaticgastroesophagealreflux.Majorcomplicationsoccurredin9(11%)patients.Stridordevelopedimmediatelyafterinsertionin3patientswithalesionwithin4cmoftheupperesophagealsphincter.Inall3patients,thestentwasremoved,andtheyweremanagedconservatively.ThreepatientshadanupperGIhemorrhagefromthetumorsiteatamediantimeintervalof26daysafterS
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 消化道 狭窄 治疗
![提示](https://static.bdocx.com/images/bang_tan.gif)